Markus Borchert - U Blox Ex Director
| UBXN Stock | CHF 71.40 0.80 1.11% |
Insider
Markus Borchert is Ex Director of U Blox Holding
| Age | 56 |
| Phone | 41 44 722 74 44 |
| Web | https://www.u-blox.com |
U Blox Management Efficiency
The company has return on total asset (ROA) of 0.0858 % which means that it generated a profit of $0.0858 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1815 %, meaning that it generated $0.1815 on every $100 dollars invested by stockholders. U Blox's management efficiency ratios could be used to measure how well U Blox manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carsten Stolz | Baloise Holding AG | 55 | |
| Gert MSc | Baloise Holding AG | 57 | |
| Marco Marotta | Relief Therapeutics Holding | 37 | |
| Ehrika Gladden | Logitech International SA | N/A | |
| Ben CFA | Logitech International SA | 46 | |
| Ingo Bank | Ams AG | 55 | |
| Laure Deppierraz | Banque Cantonale du | N/A | |
| Clemens Markstein | Baloise Holding AG | 52 | |
| JeanYves Pannatier | Banque Cantonale du | N/A | |
| Mario Kalbermatter | Banque Cantonale du | N/A | |
| Philippe Mtrailler | Banque Cantonale du | N/A | |
| Christopher Wick | Relief Therapeutics Holding | N/A | |
| Drew CroninFine | Relief Therapeutics Holding | N/A | |
| Thomas Stockmeier | Ams AG | 65 | |
| Massimo Rapparini | Logitech International SA | N/A | |
| Alexander Everke | Ams AG | 60 | |
| Dorian Bevec | Relief Therapeutics Holding | 65 | |
| Serene MPH | Relief Therapeutics Holding | N/A | |
| Fabrice Fournier | Banque Cantonale du | N/A | |
| Jack Weinstein | Relief Therapeutics Holding | 66 | |
| Stphane Jean | Banque Cantonale du | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0858 |
U Blox Holding Leadership Team
Elected by the shareholders, the U Blox's board of directors comprises two types of representatives: U Blox inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UBXN. The board's role is to monitor U Blox's management team and ensure that shareholders' interests are well served. U Blox's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, U Blox's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JeanPierre Wyss, Exec Director | ||
| Roland Jud, Chief Officer | ||
| Ulrich Looser, Ex Director | ||
| Markus Borchert, Ex Director | ||
| Andreas Thiel, Head Centers | ||
| Markus Schafer, Ex Marketing | ||
| Thomas Seiler, CEO Director | ||
| Andre Muller, Ex Chairman |
UBXN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is U Blox a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0858 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 780.46 M | |||
| Shares Outstanding | 7 M | |||
| Shares Owned By Insiders | 2.85 % | |||
| Shares Owned By Institutions | 44.66 % | |||
| Price To Earning | 34.92 X | |||
| Price To Book | 2.34 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for UBXN Stock Analysis
When running U Blox's price analysis, check to measure U Blox's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy U Blox is operating at the current time. Most of U Blox's value examination focuses on studying past and present price action to predict the probability of U Blox's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move U Blox's price. Additionally, you may evaluate how the addition of U Blox to your portfolios can decrease your overall portfolio volatility.